UPDATE : Wednesday, June 19, 2019
Chinese patients vaccinate MSD’s product in Korea. Why? by Lee Han-soo 2019-05-13 14:57
US trade agency orders Daewoong to submit Nabota’s strain by Lee Han-soo 2019-05-13 14:37
Antibody-drug conjugates on the rise as Herceptin’s patent to expire soon by Kim Yun-mi 2019-05-13 14:23
Pfizer keeps lead over multinational pharmas in 2018 sales by Lee Han-soo 2019-05-10 17:17
Xeljianz is easier to use than biologic therapies -- is it safer, however? by Kim Yun-mi 2019-05-10 15:34
[Exclusive] MSD Korea playing tricks to reduce daycare cost by Kim Yun-mi 2019-05-09 11:20
T&R Biofab, CiSTEM to co-develop rare disease treatments by Lee Han-soo 2019-05-09 11:17
‘GC Wellbeing’s placenta injection has liver regenerative effects’ by Lee Han-soo 2019-05-08 17:07
Celgene’s myelodysplastic syndrome treatment gets more insurance benefits by Lee Han-soo 2019-05-07 17:36
GC Cell to start developing CAR-T treatment for pancreatic cancer by Lee Han-soo 2019-05-07 16:10
FDA OKs Gemvax & Kael's Alzheimer treatment for P2 trials by Lee Han-soo 2019-05-07 16:09
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave by Jeong Sae-im 2019-05-07 12:08
Dong-A ST posts robust Q1 profit by Lee Han-soo 2019-05-03 16:49
Leading hepatitis C drug wins FDA nod for adolescents by Kim Yun-mi 2019-05-03 15:51
GC surpasses 200-million mark in flu vaccine production by Lee Han-soo 2019-05-03 14:39
Hanmi's short bowel syndrome treatment becomes orphan drug in US by Lee Han-soo 2019-05-03 11:42
Ministry OKs Lilly Korea’s metastatic breast cancer treatment by Lee Han-soo 2019-05-02 18:11
GC marks sluggish sales in Q1 by Lee Han-soo 2019-05-02 14:30
Daewoong logs ₩238.1 billion sales in Q1 by Lee Han-soo 2019-05-02 14:09
‘MSD Korea’s monitoring program might be privacy breach’ by Kim Yun-mi 2019-05-02 11:00
Back to Top